MICROBIOTA, METABOLIC SYNDROME, PSYCHO-INTELLECTUAL FUNCTIONING: BORDERLINES OF PATHOGENETIC CONJUGATION


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article presents the results of analysis of modern scientific medical literature on the relationship between microbiota and metabolic syndrome, their impact on the psycho-intellectual status of patients. Given that the nervous system and psycho-intellectual functioning are adversely affected by both the signal molecules produced by the microbiota and the metabolic abnormalities, it is advisable to consider these disorders within the framework of a single pathological process with common clinical and pathogenetic links. An integrated approach to this complex pathology within the framework of current trends in the development of medical science will contribute to more adequate and effective management of such category of patients.

Texto integral

Acesso é fechado

Sobre autores

Yu. Fominykh

Pavlov First St. Petersburg State Medical University

Email: jaf@mail.ru
PhD, Associate Professor, Associate Professor at the Department of Internal Diseases of the Faculty of Dentistry

Yu. Uspensky

Pavlov First St. Petersburg State Medical University; St. Petersburg State Pediatric Medical University

Bibliografia

  1. lederberg J. Infectious history. Science 2000;288:287-93.
  2. Шендеров Б.А., Голубев В.Л., Данилов А.Б., Прищепа А.В. Кишечная микробиота человека и нейродегенеративные заболевания. Неврология. 2016;Спецвыпуск. №1:7-13.
  3. Cryan J.F., Dinan T.J. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Rev Neuroscience 12 September 2012. doi: 10.1038/nrn3346.
  4. Weinstock G.M. Genomic approaches to studying the human microbiota. Nature. 2012;489:250-56.
  5. Lozupone C.A., Stombaugh J.I., Gordon J. I., et al. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220-30.
  6. Yatsunenko T., Rey F.E., Minary M.J., et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222-27.
  7. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242-49.
  8. Шендеров Б.А. Микробная экология человека и ее роль в поддержании здоровья. Метаморфозы. 2014;5:72-80. [Shenderov BА., Microbial human ecology and its role in maintaining health. Metamorfozy. 2014;5:72-80. (In Russ.)].
  9. Hanson L.A. Feeding and infant development breastfeeding and immune function. Proc. Nutr. Soc. 2007;66:384-96.
  10. Oleskin A.V., Zhilenkova O.G., Shenderov B.A., et al. Lactic-acid bacteria supplement fermented dairy products with human behaviour-modifying neuroactive compounds. J. Pharmacy Nutrition Sciences. 2014;4:199-206.
  11. Asano Y., Hiramoto T., Nishino R., et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2012;303:1288-95. doi: 10.1152/ajpgi.00341.2012.
  12. Grenham S., Clarke G., Cryan J.F., Dinan T.G. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:94-102.
  13. Newburg D.S. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J. Anim. Sci. 2009;87(Suppl.):26-34.
  14. Ben-Ari Y. Neuropaediatric and neuroarchaeology: understanding development to correct brain disorders. Acta Paediatr. 2013;102:331-334.
  15. Rhee S.H. et al. Pothoulakis C., Mayer E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 2009;6:306-314. doi: 10.1038/nrgastro.2009.35306-14
  16. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 2011;12;453-466.
  17. MacFabe D. Autism: metabolism, mitochondria, and the microbiome. Global Adv Health Med. 2013;2:52-66.
  18. Eiwegger T., Stahl B., Haidl P, et al. Prebiotic oligosaccharides:In vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr. Allergy Immunol. 2010;21:1179-1188.
  19. Severance E.G., Prandovszky E., Castiglione J., et al. Gastroenterology issues in schizophrenia: why the gut matters. Curr. Psychiatry Rep. 2015;17:27.
  20. Wu X.F., Chen P.S., Dallas S., et al. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons, Int. J. Neuropsychopharmacol. 2008;11:1123-34.
  21. Hanson LA. Feeding and infant development breastfeeding and immune function. Proc. Nutr. Soc. 2007;66:384-96.
  22. Meadow J.F., Altrichter A.E., Bateman A.C., et al. Humans differ in their personal microbial cloud. Peer J. 2015;3:e1258.
  23. Cevenini E., Monti D., Franceschi C. Inflamm-ageing. Curr Opin. Clin. Nutr. Metab. Care. 2013;16:14-20.
  24. Nibali L., Henderson B., Sadiq S.T., Donos N. Genetic dysbiosis : the role of microbial insults in chronic inflammatory diseases. J. Oral. Microbiol. 2014;6:22962. http//dx.doi.org/10.3402/jom.v6.22962.
  25. Desbonnet L., Garrett L., Clarke G., et al. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatr. Res. 2008;43:164-174. Doi: 10.1016/j. jpsychires.2008.03.009.
  26. Forsythe P., Sudo N., Dinan T., et al. Mood and gut feelings. Brain Behav Immun. 2010;24:9-16.
  27. Kimura I., Ozawa K., Inoue D., et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 2013;4:1829. doi: 10.1038/ncomms2852.
  28. Liu X., Cao S., Zhang X. Modulation of gut microbiota-brain axis by probiotics, prebiotics, and diet. J. Agric Food Chem. 2015;63:7885-95.
  29. Mahowald M.A., Rey F.E., Seedorf H., et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc. Natl. Acad. Sci. USA. 2009;106:5859-64.
  30. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;7122:1022-23.
  31. DiBaise J.K., Zhang H., Crowell M.D., et al. Gut microbiota and its possible relationship with obesity. Mayo Clin. Proc. 2008;83:460-69.
  32. Немцов В.И. Нарушения состава кишечной микрофлоры и метаболический синдром. Клинико-лабораторный консилиум. 2010;1:4-13.
  33. Wang Z., Klipfell E., Bennet B.J. Gut flora metabolism of phosphatidilcholine promotes cardiovascular disease. Nature. 2011;472:57-63.
  34. Шилов А.М., Марьяновский А.А., Петрухина Н.Б. Эндобиоценоз кишечника и метаболически - ассоциированные состояния. Лечебное дело. 2013;2:67-74.
  35. Болезни сердца и сосудов. Руководство Европейского общества кардиологов/ Под ред. А.Д. Кэмма, Т.Ф. Люшера, П.В. Серриуса. Пер. с англ. под ред. Е.В. Шляхто. М.: ГЭОТАР-Медицина, 2011. 1480c.
  36. Фоминых Ю.А., Шапорова Н.Л., Горбачева И.А., и др. Инфекционные агенты, микробиота и метаболический синдром. Дневник казанской медицинской школы. 2018;I(XIX):104-8.
  37. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128*9 million children, adolescents, and adults. The Lancet. 2017;390(10113):2627-42. https://doi. org/10.1016/S0140-6736(17)32129-3.
  38. Grundy S.M., Brewer H.B. Jr., Cleeman J.I., et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute. American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-38.
  39. Фоминых Ю.А., Шабров А.В., Успенский Ю.П., Иванов С.В. Функциональный запор у пациентов с метаболическим синдромом. Экспериментальная и клиническая гастроэнтерология. 2017;7:151-54.
  40. Старостина Е.Г., Володина М.Н., Бобров А.Е. Клинико-лабораторные корреляты уровня интеллекта (IQ) у больных сахарным диабетом 2-го типа и ожирением. Альманах клинической медицины. 2015;Спецвыпуск 1:87-94.
  41. Miller J., Kranzler J., Liu Y., et al. Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. J. Pediatr. 2006;149(2):192-98.
  42. Ordonez F.J., Rosety M.A., Camacho A., et al. Aerobic training improved low-grade inflammation in obese women with intellectual disability. J. Intellect Disabil. Res. 2014;58(6):583-90.
  43. Grondhuis S.N., Aman M.G. Overweight and obesity in youth with developmental disabilities: a call to action. J. Intellect Disabil. Res. 2014;58(9):787-99.
  44. de Winter C.F., Hermans H., Evenhuis H.M., Echteld M.A. Associations of symptoms of anxiety and depression with diabetes and cardiovascular risk factors in older people with intellectual disability. J. Intellect Disabil. Res. 2015;59(2):176-85.
  45. Cournot M., Marquie J.C., Ansiau D., et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology. 2006;67(7):1208-14.
  46. Yu Z.B., Han S.P., Cao X.G., Guo X.R. Intelligence in relation to obesity: a systematic review and metaanalysis. Obes. Rev. 2010;11(9):656-70.
  47. Singh-Manoux A., Czernichow.S., Elbaz A., et al. Obesity phenotypes in midlife and cognition in early old age: the Whitehall II cohort study. Neurology. 2012;79(8):755-62.
  48. Anstey K.J., Cherbuin N., Budge M., Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes. Rev. 2011;12(5):e426-37.
  49. Debette S., Seshadri S., Beiser A., et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011; 77(5):461-68.
  50. Fotuhi M., Do D., Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat. Rev. Neurol. 2012;8(4):189-202.
  51. Phan T.L., Curran J.L., Datto G.A. Evaluation of intelligence in an adolescent bariatric population. Surg. Obes. Relat. Dis. 2013;9(4):574-79.
  52. Belsky D.W., Caspi A., Goldman-Mellor S., et al. Is obesity associated with a decline in intelligence quotient during the first half of the life course? Am. J. Epidemiol. 2013;178(9):1461-68.
  53. Deary I.J., Crawford J.R., Hepburn D.A., et al. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes. 1993; 42(2):341-44.
  54. Волчегорский И.A., Местер Н.В., Зотова О.Г. Предикторы диабетической энцефалопатии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2006;106(9):12-16.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies